Carregant...
Her-2/neu amplification and breast cancer survival: Results from the Shanghai breast cancer study
Her-2/neu is a member of the epidermal growth factor receptor family that has been found to be overexpressed or amplified in ~20-30% of breast cancers. Negative prognosticators and a shortened survival have been shown to be associated with these changes in Her-2/neu, but previous studies have consis...
Guardat en:
| Publicat a: | Oncol Rep |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6519112/ https://ncbi.nlm.nih.gov/pubmed/18425397 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|